Study Finds Traditional Fecal Transplant Outperforms New Pill in Severe C. Diff. Cases

Study finds traditional fecal transplant outperforms new pill in severe C. diff. cases

A new comparative study led by researchers at the UNC School of Medicine found that a new therapy for prevention of recurrent Clostridioides difficile infection may be less effective than traditional therapy when it comes to preventing severe disease over time.

New Treatment for C. Diff. Infection May be Less Effective Than Traditional Therapy, Study Finds

A comparative study led by researchers at the UNC School of Medicine found that a new therapy for prevention of recurrent Clostridioides difficile infection may be less effective than traditional therapy when it comes to preventing severe disease over time.

Caffeic acid phenethyl ester protects Clostridioides difficile infection by toxin inhibition and microbiota modulation

Clostridioides difficile infection (CDI) is the leading cause of hospital-acquired diarrhea that seriously threatens public health. The disruption of normal gut microbiota by the use of broad-spectrum antimicrobial agents enables C. difficile to proliferate in the colon. The emergence and prevalence of hypervirulent C. difficile strains result in increased morbidity, mortality, and high recurrence rates of CDI, thus creating a pressing need for …